A new trading day began on Monday, with Outset Medical Inc (NASDAQ: OM) stock price down -9.29% from the previous day of trading, before settling in for the closing price of $1.40. OM’s price has ranged from $0.44 to $5.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 90.53% over the last five years. Meanwhile, its annual earnings per share averaged 26.00%. With a float of $48.29 million, this company’s outstanding shares have now reached $52.54 million.
The firm has a total of 480 workers. Let’s measure their productivity. In terms of profitability, gross margin is 30.97%, operating margin of -112.32%, and the pretax margin is -122.32%.
Outset Medical Inc (OM) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Outset Medical Inc is 8.10%, while institutional ownership is 48.61%. The most recent insider transaction that took place on Nov 15 ’24, was worth 4,516. In this transaction Chair and CEO of this company sold 5,645 shares at a rate of $0.80, taking the stock ownership to the 904,851 shares. Before that another transaction happened on Nov 15 ’24, when Company’s SVP Operations and R&D sold 1,375 for $0.80, making the entire transaction worth $1,100. This insider now owns 238,022 shares in total.
Outset Medical Inc (OM) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 26.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.80% during the next five years compared to -15.08% drop over the previous five years of trading.
Outset Medical Inc (NASDAQ: OM) Trading Performance Indicators
Here are Outset Medical Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.77, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of Outset Medical Inc (OM)
Analysing the last 5-days average volume posted by the [Outset Medical Inc, OM], we can find that recorded value of 2.03 million was lower than the volume posted last year of 3.08 million. As of the previous 9 days, the stock’s Stochastic %D was 64.46%. Additionally, its Average True Range was 0.16.
During the past 100 days, Outset Medical Inc’s (OM) raw stochastic average was set at 66.53%, which indicates a significant increase from 42.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 117.20% in the past 14 days, which was lower than the 119.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9383, while its 200-day Moving Average is $2.0127. Now, the first resistance to watch is $1.5533. This is followed by the second major resistance level at $1.8367. The third major resistance level sits at $1.9833. If the price goes on to break the first support level at $1.1233, it is likely to go to the next support level at $0.9767. Now, if the price goes above the second support level, the third support stands at $0.6933.
Outset Medical Inc (NASDAQ: OM) Key Stats
With a market capitalization of 79.85 million, the company has a total of 52,542K Shares Outstanding. Currently, annual sales are 130,380 K while annual income is -172,800 K. The company’s previous quarter sales were 28,670 K while its latest quarter income was -27,940 K.
